Large-scale testing (Phase 3)WithdrawnNCT02978651
What this trial is testing
Pitolisant (BF2.649) in the Treatment of Excessive Daytime Sleepiness in Patients With Obstructive Sleep Apnoea Syndrome, Treated or Not by Nasal Continuous Positive Airway Pressure, But Still Complaining of Excessive Daytime Sleepiness
Who this might be right for
Excessive Daytime SleepinessObstructive Sleep Apnea
Bioprojet